NASDAQ:REGN | Free Cash Flow | REGENERON PHARMACEUTICALS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2008-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$1.08B
2025-12-31$1.17B
2025-03-31$1.05B
2024-12-31$1.26B
2024-03-31$1.51B
2023-12-31$1.09B
2023-03-31$1.37B
2022-12-31$1.72B
2022-03-31$2.1B
2021-12-31$2.37B
2021-03-31$668.5M
2020-12-31$1.23B
2020-03-31$698M
2019-12-31$787.4M
2019-03-31$897M
2018-12-31$728.8M
2018-03-31$618.8M
2017-12-31$566.94M
2017-03-31$355.9M
2016-12-31$390.38M
2016-03-31$44.99M
2015-12-31$281.82M
2015-03-31-$101.73M
2014-12-31$198.18M
2014-03-31$53.53M
2013-12-31$281.73M
2013-03-31$86.25M
2012-12-31$93.19M
2012-03-31-$87.04M
2011-12-31-$50.32M
2011-03-31-$10.58M
2010-12-31-$40.85M
2010-03-31-$9.58M
2009-12-31-$44.11M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$4.98B
2024-12-31$4.42B
2023-12-31$4.59B
2022-12-31$5.01B
2021-12-31$7.08B
2020-12-31$2.62B
2019-12-31$2.43B
2018-12-31$2.2B
2017-12-31$1.31B
2016-12-31$1.49B
2015-12-31$1.33B
2014-12-31$752.44M
2013-12-31$588.6M
2012-12-31-$74.62M
2011-12-31-$141.68M
2010-12-31$99.22M
2009-12-31-$69.94M
2008-12-31-$89.09M